This rare condition can lead to: low plasma carnitine progressive cardiomyopathy, or heart muscle disease skeletal myopathy hypoglycemia hypoammonemia weak muscles in the hips, shoulders upper arms, legs, neck, and jaw muscles Untreated it is fatal
What to verify tirzepatide, peptide evidence quality, safety and contraindications How to use it Use this information to prepare sharper questions for a licensed provider
When combined with increased physical activity, these injections can even contribute to weight loss
MT-2 is not FDA-approved and carries unresolved safety concerns
Lee et al., 2021
[DOI] [PMC free article] [PubMed] [Google Scholar] 128.Eisenstein A., Hilliard B.K., Pope S.D., Zhang C., Taskar P., Waizman D.A., Israni-Winger K., Tian H., Luan H.H., Wang A